Corcept Therapeutics reported $5.02M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Eli Lilly USD 65M 25M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Merck USD 96M 27M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025